Abstract | BACKGROUND: OBJECTIVE: PATIENTS AND METHODS: Eighty-five patients with proven leishmaniasis were recruited and randomly treated by one of the two methods, either by conventional injection or by mesotherapy administration weekly. Lesion characteristics were evaluated at every treatment session as well as 1 week, 1 month and 3 months after cessation of treatment. RESULTS: The improvement in lesions was similar in both groups, while it was noted sooner in mesotherapy group with less amount of drug usage (P = 0.005 and 0.016 respectively). Also, patients treated with mesotherapy experienced less pain severity (P = 0.005). CONCLUSION:
|
Authors | Mansour Nassiri Kashani, Bardia Sadr, Mohammad Ali Nilforoushzadeh, Mahfar Arasteh, Shahab Babakoohi, Alireza Firooz |
Journal | International journal of dermatology
(Int J Dermatol)
Vol. 49
Issue 9
Pg. 1034-7
(Sep 2010)
ISSN: 1365-4632 [Electronic] England |
PMID | 20883265
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © 2010 The International Society of Dermatology. |
Chemical References |
- Organometallic Compounds
- Meglumine
- Meglumine Antimoniate
|
Topics |
- Acute Disease
- Adolescent
- Adult
- Child
- Female
- Humans
- Injections, Intralesional
(instrumentation, methods)
- Leishmaniasis, Cutaneous
(drug therapy)
- Male
- Meglumine
(administration & dosage)
- Meglumine Antimoniate
- Mesotherapy
(instrumentation)
- Organometallic Compounds
(administration & dosage)
- Pain
(prevention & control)
- Treatment Outcome
- Young Adult
|